Robust and Cost-Effective Pharmacological Immunosuppression Enables Establishment of Nigerian Patient-Derived Xenograft (PDX) Models of Triple-Negative Breast Cancer (TNBC) in Low-Resource SettingsUzoamaka Adaobi Okoli, Iroka J. Udeinya|Research Square|2025Cited by 0